perspectives
We are passionate about using our voices to advance our mission of developing life-transforming therapies for people living with serious muscle diseases.
We are passionate about using our voices to advance our mission of developing life-transforming therapies for people living with serious muscle diseases.
Oct 7, 2021
From the Trenches:
A LifeSci VC blog
A LifeSci VC blog
Empowering Therapeutic Advances with Early Patient Engagement
by Joshua Brumm,
President & CEO of Dyne
Read more
by Joshua Brumm,
President & CEO of Dyne
Sep 15, 2021 | Blog
Starting a New Tradition of Support
by Molly White, Dyne’s vice president, global head of patient advocacy and engagement
Read moreJul 8, 2021 |
Playing To Win: Building A Position Of Strength In Biotech
by Josh Brumm
Read moreApril 28, 2021 | BLOG
Toward a brighter future: targeting the genetic basis of rare muscle diseases
By Romesh Subramanian, Ph.D.
Read moreApril 8, 2021 | BLOG
Scaling culture with growth: how to maintain your startup’s “special sauce”
By Joshua Brumm
Read moreJan 8, 2021 | Life Science Leader panel
Preparing to pitch in a virtual world
Featuring Joshua Brumm
WatchDec 16, 2020 | BLOG
Beyond the balance sheet: thinking broadly about dilution in building a transformative biotech
By Joshua Brumm
Read moreDec 14, 2020 | BLOG
Voice of the patient – the biopharma perspective
By Molly White
Read moreOct 21, 2020 | PODCAST
FSHD Society Radio
By Molly White
ListenOct 13, 2020 | BLOG
The power of hope: a joint perspective on finding balance in the search for life-changing therapies
By Joachim Boekelmann and Joshua Brumm
Read moreadditional content
Hear more from Dyne Therapeutics
Hear more from our CEO, Joshua Brumm
It has been a pleasure hosting the next generation of leaders in patient advocacy. We look forward to watching the impact you will have and the difference you will make amplifying the voices of patients.
